Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
9
|
| pubmed:dateCreated |
1991-1-31
|
| pubmed:abstractText |
Daily subcutaneous infusion of deferoxamine in thalassemia and other transfusion dependent-patients can successfully treat iron overload, but most patients, mainly young children and teenagers may not comply with this method. Experience with nightly intravenous infusion of deferoxamine (8 g) through a subcutaneous-port over 5 out of 21 days, is reported in 4 children with dramatic improvement in clinical status, ferritin levels and quality of life.
|
| pubmed:language |
fre
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0031-4021
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
45
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
619-23
|
| pubmed:dateRevised |
2006-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:2175425-Adolescent,
pubmed-meshheading:2175425-Child,
pubmed-meshheading:2175425-Child, Hospitalized,
pubmed-meshheading:2175425-Deferoxamine,
pubmed-meshheading:2175425-Follow-Up Studies,
pubmed-meshheading:2175425-Humans,
pubmed-meshheading:2175425-Infusion Pumps, Implantable,
pubmed-meshheading:2175425-Infusions, Intravenous,
pubmed-meshheading:2175425-Night Care,
pubmed-meshheading:2175425-Thalassemia
|
| pubmed:year |
1990
|
| pubmed:articleTitle |
[Intravenous administration of deferoxamine in over-night hospitalization: efficacy and good psychological tolerance in thalassemic children].
|
| pubmed:affiliation |
Unité d'hématologie-oncologie pédiatrique (services de pédiatrie des Prs A Baudoing et M Bost), Centre hospitalier de Grenoble, France.
|
| pubmed:publicationType |
Journal Article,
English Abstract
|